Search

Search Constraints

You searched for: Author/Creator Marrone, A.

Search Results

1. HBsAg kinetics in chronic hepatitis D during interferon therapy: on‐treatment prediction of response. Issue 6 (22nd July 2016)

4. Entecavir monotherapy improves renal function in patients developing renal side effects during long-term tenofovir treatment without compromising virological response: A multicenter real-life study in 103 patients. Issue 1 (16th February 2017)

5. Immunosuppression-driven HBV reactivation in patients with resolved HBV infection correlates with a relevant risk of death and with evolution towards active chronical infection. (10th February 2016)

6. THE TM6SF2 E167 K VARIANT IS AN INDEPENDENT PREDICTOR OF SEVERE LIVER STEATOSIS IN CHRONIC HEPATITIS C. (15th February 2015)

7. A hyper-glycosylation of HBV surface major hydrophilic region correlates with immunosuppression-driven HBV reactivation and hampers HBsAg recognition in vitro. (15th February 2015)

8. Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C. Issue 8 (7th January 2013)

9. Hepatitis C virus eradication by direct antiviral agents improves carotid atherosclerosis in patients with advanced fibrosis/compensated cirrhosis. Issue 1 (February 2018)

10. Eighteen‐month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy. Issue 2 (29th November 2017)